GOLDSTEIN DOV A MD - 24 Jun 2025 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Dov A. Goldstein
Issuer symbol
GANX
Transactions as of
24 Jun 2025
Transactions value $
$0
Form type
4
Filing time
25 Jun 2025, 17:30:14 UTC
Previous filing
25 Feb 2025
Next filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GOLDSTEIN DOV A MD Director C/O GAIN THERAPEUTICS, INC., 4800 MONTGOMERY LANE, SUITE 220, BETHESDA /s/ Dov A. Goldstein 25 Jun 2025 0001120478

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Stock Option (right to buy) Award $0 +15K $0.00 15K 24 Jun 2025 Common Stock 15K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.